Journal article

The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years

AB Spurdle, JL Hopper, X Chen, GS Dite, J Cui, MRE McCredie, GG Giles, S Ellis-Steinborner, DJ Venter, B Newman, MC Southey, G Chenevix-Trench

Cancer Epidemiology Biomarkers and Prevention | AMER ASSOC CANCER RESEARCH | Published : 2002

Abstract

The BRCA2 N372H nonconservative amino acid substitution polymorphism appears to affect fetal survival in a sex-dependent manner, and the HH genotype was found to be associated with a 1.3-fold risk of breast cancer from pooling five case-control studies of Northern European women. We investigated whether the BRCA2 N372H polymorphism was associated with breast cancer in Australian women using a population-based case-control design. The BRCA2 372 genotype was determined in 1397 cases under the age of 60 years at diagnosis of a first primary breast cancer and in 775 population-sampled controls frequency matched for age. Case-control analyses and comparisons of genotype distributions were conduct..

View full abstract